SCHEMBL20095615

SCHEMBL20095615

CN(CCO)C1CCCC(C(F)(F)F)C1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7114292 0.77
SCHEMBL20095596 0.75
SCHEMBL7114265 0.75 HRH4 (0.39)
SCHEMBL20096211 0.74
SCHEMBL20096219 0.73 CACNA1C (0.30) CACNA1C
SCHEMBL9949828 0.73 HRH4 (0.42)
SCHEMBL7121348 0.73 HRH4 (0.42)
SCHEMBL803958 0.73 HRH4 (0.42)
SCHEMBL20063776 0.72 SCN9A (0.35)
SCHEMBL20073031 0.72 SCN9A (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018072602-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2018-04-26 WO disclosed